Search Results - "Mishell, DR"

Refine Results
  1. 1

    Safety and efficacy of Implanon™, a single-rod implantable contraceptive containing etonogestrel by Funk, Sidney, Miller, Michael M., Mishell, Daniel R., Archer, David F., Poindexter, Alfred, Schmidt, Juergen, Zampaglione, Edio

    Published in Contraception (Stoneham) (01-05-2005)
    “…The safety and efficacy of a single-rod implantable contraceptive containing etonogestrel (Implanon™) were investigated in a multicenter clinical trial…”
    Get full text
    Journal Article
  2. 2

    Female contraception over 40 by Baird, DT, Castelo-Branco, C, Collins, J, Evers, JLH, Glasier, A, La Vecchia, C, Leridon, H, Mishell, DR, Wellings, K, Arisi, E, Benagiano, G, Bitzer, J, Crosignani, PG, Diczfalusy, E, Lanzone, A, Skouby, SO, Stock, G, Volpe, A

    Published in Human reproduction update (01-11-2009)
    “…BACKGROUND The majority of women 40–49 years of age need an effective method of contraception because the decline in fertility with age is an insufficient…”
    Get full text
    Journal Article
  3. 3
  4. 4

    State of the art in hormonal contraception: an overview by Mishell, Daniel R.

    “…In June 2001, together with an esteemed group of colleagues, I had the opportunity to preside over a 2-day conference presented by the National Institute of…”
    Get full text
    Journal Article
  5. 5

    Pharmacokinetics of depot medroxyprogesterone acetate contraception by Mishell, Jr, D R

    Published in Journal of reproductive medicine (01-05-1996)
    “…Depot medroxyprogesterone acetate (DMPA) is an aqueous suspension of 17-acetoxy 6-methyl progestin administered by intramuscular injection for long-term…”
    Get full text
    Journal Article
  6. 6

    Levonorgestrel capsule implants in the United States: a 5-year study by Sivin, Irving, Mishell, D.R, Darney, Philip, Wan, Livia, Christ, Mercedes

    Published in Obstetrics and gynecology (New York. 1953) (01-09-1998)
    “…Objective: To measure effectiveness, adverse event experience, and acceptability of the Food and Drug Administration–approved variant of levonorgestrel capsule…”
    Get full text
    Journal Article
  7. 7

    Progestin-only contraceptive rings by Brache, Vivian, Alvarez-Sanchez, Francisco, Faundes, Anibal, Jackanicz, Theodore, Mishell, Daniel R., Lähteenmäki, Pekka

    Published in Steroids (01-10-2000)
    “…Several progestin-only long acting contraceptives are currently available in the form of implants or injectables. Vaginal rings are another contraceptive…”
    Get full text
    Journal Article Conference Proceeding
  8. 8
  9. 9

    Comparison of ovarian follicular activity during treatment with a monthly injectable contraceptive and a low-dose oral contraceptive by Jain, John K, Ota, Felicia, Mishell, Daniel R

    Published in Contraception (Stoneham) (01-03-2000)
    “…Ovarian follicular development occurs during treatment with combined and progestin-only oral contraceptive (OC) pills and progestin-containing subdermal…”
    Get full text
    Journal Article
  10. 10

    The significance of bleeding patterns in Norplant implant users by Shoupe, D, Mishell, Jr, D R, Bopp, B L, Fielding, M

    Published in Obstetrics and gynecology (New York. 1953) (01-02-1991)
    “…The purpose of this study was to examine the bleeding patterns of 234 Norplant users during 5 years of use and to identify the bleeding patterns of users who…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Premenstrual disorders: epidemiology and disease burden by Mishell, Jr, Daniel R

    Published in The American journal of managed care (01-12-2005)
    “…Many women of childbearing age experience a variety of symptoms related to the menstrual cycle that may be limited to mild discomfort or extend to premenstrual…”
    Get full text
    Journal Article
  13. 13

    Noncontraceptive benefits of oral contraceptives by MISHELL, D. R

    Published in Journal of reproductive medicine (01-12-1993)
    “…The noncontraceptive health benefits of oral contraceptives were initially summarized a decade ago. Studies conducted in the last decade confirmed the findings…”
    Get full text
    Conference Proceeding Journal Article
  14. 14

    Comparison of pharmacodynamic properties of various estrogen formulations by Mashchak, C A, Lobo, R A, Dozono-Takano, R, Eggena, P, Nakamura, R M, Brenner, P F, Mishell, Jr, D R

    “…A group of 23 healthy postmenopausal women received one or more 2-week courses of daily administration of the following estrogen preparations: piperazine…”
    Get more information
    Journal Article
  15. 15

    Estrogen replacement therapy: an overview by Mishell, Jr, D R

    “…Levels of circulating estrogen fall during the perimenopausal period, resulting in changes in the postmenopausal woman's genitourinary tract, central nervous…”
    Get more information
    Journal Article
  16. 16

    Characteristics of ovarian follicular development in Norplant users by Shoupe, D, Horenstein, J, Mishell, Jr, D R, Lacarra, M, Medearis, A

    Published in Fertility and sterility (01-04-1991)
    “…Daily transvaginal ultrasound (US) scanning of the ovaries to assess follicular development and daily blood sampling were performed on 19 Norplant (Leiras,…”
    Get more information
    Journal Article
  17. 17

    Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol by Goebelsmann, U, Mashchak, C A, Mishell, Jr, D R

    “…The pronounced hepatic impact of oral ethinyl estradiol has been attributed by some to its so-called first-pass effect through the liver as only some 40% of…”
    Get more information
    Journal Article
  18. 18

    Dose-finding study of a contraceptive ring releasing norethindrone acetate/ethinyl estradiol by Ballagh, S A, Mishell, Jr, D R, Jackanicz, T M, Lacarra, M, Eggena, P

    Published in Contraception (Stoneham) (01-12-1994)
    “…A core design contraceptive vaginal ring (CVR) with average daily release of 650 mcg of norethindrone acetate (NA) and 30 mcg of ethinyl estradiol (EE)…”
    Get more information
    Journal Article
  19. 19

    Increase in US Pearl Index (PI) over time not due to obesity in a recent large contraceptive study by Kaunitz, AM, Mishell, DR, Foegh, M

    “…To compare AG200 - 15, a contraceptive patch with low-dose ethinylestradiol (EE) and levonorgestrel (LNG), vs. a combination oral contraceptive (COC)…”
    Get full text
    Journal Article
  20. 20

    Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study by Kjos, S L, Shoupe, D, Douyan, S, Friedman, R L, Bernstein, G S, Mestman, J H, Mishell, Jr, D R

    “…Women with recent gestational diabetes mellitus were randomly assigned to one of two low-dose oral contraceptives to evaluate the effect of low-dose oral…”
    Get more information
    Journal Article